Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR pharmacogenomics: the story continues to mutate and evolve.

American journal of pharmacogenomics : genomics-related research in drug development and clinical practice - 1 Jan 2005

Desai Apurva A, Ratain Mark J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Clinical Trials, Phase III as Topic
Share to ErbB Receptors
Share to Gefitinib

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Protein-Tyrosine Kinases

Share to Quinazolines

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 15813677
DOI: 10.2165/00129785-200505020-00007

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR pharmacogenomics: the story continues to mutate and evolve.PMID 15813677Read ↗

Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?Semantic proximity Read ↗

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired ResistanceSemantic proximity Read ↗

Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers.Semantic proximity Read ↗

EGFR mutations and EGFR tyrosine kinase inhibitors.Semantic proximity Read ↗

Cancer Pharmacogenomics: Early Promise, But Concerted Effort NeededSemantic proximity Read ↗

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceSemantic proximity Read ↗

EGFR testing in lung cancer is ready for prime time.Semantic proximity Read ↗

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesSemantic proximity Read ↗

Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locationsSemantic proximity Read ↗

Genome-wide profiling identifies the genetic dependencies of cell death following EGFR inhibitionSemantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapySemantic proximity Read ↗

The molecular pathology of cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.